Parthenon posts 90% IRR on med tech deal

Parthenon Capital has sold its controlling stake in Spheris, a US medical transcription business, to private equity groups Warburg Pincus and Soros Private Equity for an undisclosed amount.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this